Home › NDC Lookup › Ingredients › Paroxetine Hydrochloride › 65862-0154-30
⚪image loading
(from DailyMed)

Paroxetine Hydrochloride 10 mg Tablet, Film Coated, 30-count — NDC 65862-154-30 (Billing 65862-0154-30)

by Aurobindo Pharma Limited · 30 TABLET, FILM COATED in 1 BOTTLE

This is a package of 30 tablets of Paroxetine Hydrochloride 10 mg Tablet, Film Coated from Aurobindo Pharma Limited, marketed since Jul 2007 and currently FDA-listed; retail pharmacies pay about $0.0619 per tablet (NADAC). It is the main listing for this product, which comes in 6 package sizes.

NDC 65862-0154-30
🏷️ FDA NDC (as labeled) 65862-154-30 billing pads the product segment with a zero
This package
Contains30-count Cost per ea$0.0619 NADAC Per package$1.86 / 30 tablets Pack sizes6 compare ↓
Also priced by: Part D plans $0.2824/unit — full pricing hub ↓
Main listing for product 65862-154 · Also comes in: 90 tablets 65862-154-90 100 tablets 65862-154-01 500 tablets 65862-154-05 1000 tablets 65862-154-99 5000 tablets 65862-154-59
On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 1, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Other active recalls for Paroxetine Hydrochloride (different manufacturers) — 4 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Nov 1, 2023 — Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine (Apotex Corp.) · FDA recall D-0121-2024
Class II · Nov 1, 2023 — Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine (Apotex Corp.) · FDA recall D-0119-2024
Class II · Nov 1, 2023 — Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine (Apotex Corp.) · FDA recall D-0120-2024
Class II · Nov 1, 2023 — Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine (Apotex Corp.) · FDA recall D-0122-2024
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 65862-154-30
Product NDC 65862-154
11-digit billing NDC 65862015430
NCPDP billing unit EA — each (per item)
SPL Set ID 2c49490d-1138-4dfd-8d1f-f81f235a41af
DEA schedule Non-controlled
Marketing category DRUG FOR FURTHER PROCESSING
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2007-07-25
Dosage form TABLET, FILM COATED
Substance PAROXETINE HYDROCHLORIDE HEMIHYDRATE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 046222
GCN 16364
HICL code 007344
Ingredient (HICL) Paroxetine Hcl
HIC1 code H
Therapeutic class — broad (HIC1) Nervous System (Except Autonomic)
HIC2 code H2
Therapeutic class — intermediate (HIC2) Psychoactive Drugs
HIC3 code H2S
Therapeutic class — specific (HIC3) Selective Serotonin Reuptake Inhibitor (Ssris)
AHFS code 28:16.04.20
AHFS class Selective-Serotonin Reuptake Inhibitors
FDB label name PAROXETINE HCL 10 MG TABLET
FDB brand name Paroxetine Hcl
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 046222
  • GCN: 16364
  • HICL (First Databank): 007344
  • AHFS class code: 28:16.04.20
Why two NDCs? The FDA registers this code as 65862-154-30 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 65862-0154-30. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name PAROXETINE HCL 10 MG TABLET Ingredient Paroxetine Hcl
📗 Our plain-language guide HelloPharmacist
  • It depends on the product. Tablets and oral suspension treat depression, OCD, panic disorder, social anxiety, generalized anxiety, and PTSD in adults. Extended-release tablets trea...
  • Take it once a day, usually in the morning, with or without food. The menopause capsule is taken at bedtime. Swallow extended-release tablets whole, and shake the suspension well....
  • The most common are nausea, sleepiness, dry mouth, sweating, constipation or diarrhea, dizziness, trouble sleeping, and sexual side effects. Tell me or your doctor if they're bothe...
  • Yes. Never combine it with MAOIs, thioridazine, or pimozide. Be careful with other serotonin-affecting drugs like triptans, tramadol, or St. John's Wort, and with aspirin, NSAIDs,...
📖 Read our full Paroxetine guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
1
Nutrient depletion considerations

Paroxetine may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Paroxetine nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.062 $1.86 / 30 tablets
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · Q2 2026 $0.2824 $8.47 / 30 tablets
NADAC price history (per ea) — tap or hover for the price & month
Jan 2022 Aug 2022 Jan 2026 Sep 2026 $0.077 $0.062
▼ Down 10% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
65862-0154-01 65862-154-01 100 TABLET, FILM COATED in 1 BOTTLE — — 2007-07-25 — Active
65862-0154-05 65862-154-05 500 TABLET, FILM COATED in 1 BOTTLE — — 2007-07-25 — Active
65862-0154-30 You're viewing this Main listing 30 TABLET, FILM COATED in 1 BOTTLE $0.0619 / ea $1.86 2007-07-25 — Active
65862-0154-90 65862-154-90 90 TABLET, FILM COATED in 1 BOTTLE — — 2007-07-25 — Active
65862-0154-99 65862-154-99 1000 TABLET, FILM COATED in 1 BOTTLE — — 2007-07-25 — Active
65862-0154-59 65862-154-59 5000 TABLET, FILM COATED in 1 BAG — — — — Active

You're viewing the smallest of 6 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This is a 30-count package — 30 tablet, film coated in 1 bottle.
How does this package differ from NDC 65862-0154-90?
Both are Paroxetine Hydrochloride 10 mg Tablet, Film Coated — the drug itself is identical. This page's package is the 30-count one, while NDC 65862-0154-90 is the 90 tablets package.
What NDC number is used to bill for this package of Paroxetine Hydrochloride 10 mg Tablet, Film Coated?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Paroxetine 10 mg 00378-7001-10 Mylan 1000 tablets $0.062 AB Availability likely —
Paroxetine 10 mg 00904-5676-61 Major 1 tablet $0.062 AB Availability likely —
Paroxetine 10 mg 16714-0181-01 NorthStar 30 tablets $0.062 AB Availability likely —
Paroxetine 10 mg 43547-0347-03 Solco 30 tablets $0.062 AB Availability likely —
Paroxetine 10 mg 50268-0640-15 AvPAK 1 tablet $0.062 AB Availability likely —
Paroxetine 10 mg 60505-0097-01 Apotex 30 tablets $0.062 AB Availability likely —
Paroxetine 10 mg 62135-0541-90 Chartwell 90 tablets $0.062 AB Availability likely —
Paroxetine Hydrochloride 10 mgthis 65862-0154-30 Aurobindo 30 tablets $0.062 — Availability likely —
Paroxetine 10 mg 68084-0044-01 American 1 tablet $0.062 AB Availability likely —
paroxetine hydrochloride 10 mg 69584-0671-03 Oxford 30 tablets $0.062 AB Availability likely —
Paroxetine 10 mg 00615-8359-39 NCS 30 tablets — AB FDA listed —
Paroxetine 10 mg 13107-0154-01 Aurolife 100 tablets — AB FDA listed —
Paroxetine 10 mg 50090-1297-00 A-S 90 tablets — AB FDA listed —
Paroxetine 10 mg 55289-0037-45 PD-Rx 45 tablets — AB FDA listed —
Paroxetine 10 mg 60429-0734-10 Golden 1000 tablets — AB FDA listed —
Paxil 10 mg 60505-4517-03 Apotex 30 tablets — AB FDA listed —
Paroxetine 10 mg 63187-0190-30 Proficient 30 tablets — AB FDA listed —
Paroxetine 10 mg 65841-0097-01 Zydus 100 tablets — AB FDA listed —
Paroxetine 10 mg 68071-1740-01 NuCare 30 tablets — AB FDA listed —
Paroxetine 10 mg 68071-2535-09 NuCare 90 tablets — AB FDA listed —
Paroxetine 10 mg 68071-3843-01 NuCare 30 tablets — AB FDA listed —
Paroxetine 10 mg 68071-5304-09 NuCare 90 tablets — AB FDA listed —
Paroxetine 10 mg 68382-0097-01 Zydus 100 tablets — AB FDA listed —
Paroxetine 10 mg 68788-0797-01 Preferred 100 tablets — AB FDA listed —
Paroxetine 10 mg 68788-8829-01 Preferred 100 tablets — AB FDA listed —
Paroxetine 10 mg 69117-0024-01 Yiling 30 tablets — AB FDA listed —
Paroxetine 10 mg 70518-1406-00 REMEDYREPACK 30 tablets — AB Discontinued —
Paroxetine 10 mg 70518-2376-00 REMEDYREPACK 1 tablet — AB FDA listed —
Paroxetine 10 mg 70518-2574-00 REMEDYREPACK 90 tablets — AB Discontinued —
Paroxetine 10 mg 70518-3430-00 REMEDYREPACK 90 tablets — AB Discontinued —
Paroxetine 10 mg 71205-0527-30 Proficient 30 tablets — AB FDA listed —
Paroxetine 10 mg 71335-0544-01 Bryant 30 tablets — AB FDA listed —
Paroxetine 10 mg 71610-0204-60 Aphena 90 tablets — AB FDA listed —
Paroxetine 10 mg 72189-0492-30 Direct_Rx 30 tablets — AB FDA listed —
Paroxetine 10 mg 72789-0379-90 PD-Rx 90 tablets — AB FDA listed —
Paroxetine 10 mg 76420-0716-01 Asclemed 100 tablets — AB FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2007
On the market since
Jul 2007
📍
2026
Currently FDA-listed
19 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAurobindo Pharma Limited
Labeler code65862
First marketedJul 2007
Product typeDrug For Further Processing
Portfolio1,456 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full FDA label FDA SPL

The complete FDA label for this product, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Listed for further processing / repackaging

What "drug for further processing" means

FDA lists this package under the "drug for further processing" marketing category: Aurobindo Pharma Limited supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) ✓ Available
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Drug For Further Processing". Products approved under an application carry an NDA, ANDA, or BLA number.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Aurobindo Pharma Limited. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 5 other package presentations of this same product, including 90 tablets (65862-0154-90), 100 tablets (65862-0154-01), 500 tablets (65862-0154-05). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Aurobindo Pharma Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 65862-0149-01 · Aurobindo 65862-0155-01 · Aurobindo →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.